WASHINGTON, Nov. 13, 2017
/PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq:
VNDA) today announced that it will participate at the following
upcoming investor conferences in November
2017.
The Stifel 2017 Healthcare Conference in New York City on Tuesday, November 14, 2017. A corporate
presentation is scheduled for 11:45 a.m.
Eastern Time.
The Jefferies 2017 London Healthcare Conference in London, England on November 15-16, 2017. A corporate presentation is
scheduled for Wednesday, November 15,
2017 at 11:20 a.m. Greenwich
Mean Time (6:20 a.m. Eastern
Time).
The 29th Annual Piper Jaffray Healthcare Conference
in New York City on Wednesday, November 29, 2017. A corporate
presentation is scheduled for 3:00 p.m.
Eastern Time.
The corporate presentations given at the Stifel, Jefferies and
Piper conferences will be available live on Vanda's corporate
website, where they also will be archived for 30 days. To access
the presentations, go to Vanda's website at www.vandapharma.com and
click on the Presentations tab on the Investor Relations page.
Please connect to the website several minutes prior to the start of
the live presentations.
About Vanda Pharmaceuticals Inc.
Vanda is a global biopharmaceutical company focused on the
development and commercialization of innovative therapies to
address high unmet medical needs and improve the lives of patients.
For more on Vanda, please visit www.vandapharma.com.
Company Contact:
Jim
Kelly
Executive Vice President and Chief Financial Officer
Vanda Pharmaceuticals Inc.
(202) 734-3428
jim.kelly@vandapharma.com
View original
content:http://www.prnewswire.com/news-releases/vanda-pharmaceuticals-announces-participation-at-november-2017-investor-conferences-300554532.html
SOURCE Vanda Pharmaceuticals Inc.